• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Exact Sciences Corp.

< Previous 1 2 Next >
News headline image
Exact Sciences Stockholders Approve Acquisition by Abbott
February 20, 2026
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results
February 13, 2026
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests
February 03, 2026
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide
February 03, 2026
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS
December 11, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium
November 24, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome’s Blood-Based Colorectal Cancer Screening Tests
November 10, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test
November 07, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences to Participate in November Investor Conference
November 04, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Announces Third Quarter 2025 Results
November 03, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps
October 27, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Schedules Third Quarter 2025 Earnings Call
October 08, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
New Study in Journal of the National Cancer Institute Finds Cologuard Plus™ Provides the Most Life-Years Gained with the Fewest Colonoscopies
October 07, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test
September 22, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
September 10, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences to Participate in September Investor Conferences
August 19, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Announces Second Quarter 2025 Results
August 06, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests
August 06, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test
July 31, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Schedules Second Quarter 2025 Earnings Call
July 14, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Announces Medicare Coverage for Oncodetect™ Molecular Residual Disease Test in Colorectal Cancer
July 09, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap
May 28, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences to Participate in June Investor Conference
May 27, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025
May 22, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Earns 2025 Great Place To Work® Certification™
May 12, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences to Participate in May Investor Conference
May 02, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Announces First-Quarter 2025 Results
May 01, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025
April 29, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test
April 22, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
News headline image
JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups
April 14, 2025
From Exact Sciences Corp.
Via Business Wire
Tickers EXAS
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap